Photo of Donna Reuter

Leveraging her experiences as a practitioner in the healthcare industry, Donna capably serves clients with her industry experience and her commitment to achieving client goals.

Donna is a healthcare associate in the Washington D.C. office, and her practice focuses on serving healthcare payer, provider, association, and industry clients in a broad array of legal matters spanning both litigation and regulatory compliance. She has previously worked on a variety of disputes involving areas of ERISA; medical malpractice; COVID-19; fraud, waste and abuse; intellectual property; and more.

Donna draws from her prior career as a pharmacist to inform her practice of the law: as a pharmacy manager for a major retail chain, and later as a clinical review pharmacist for a nationwide pharmacy benefit manager in Minnesota. She understands claims adjudication and billing processes, the pharmacy distribution chain, formulary management and utilization review processes, controlled substances laws, and pharmaceutical and healthcare adjacent areas.

In addition to her dedication to pro bono work, Donna enjoys mentoring, and is co-chair of the Minnesota Chapter of the Federal Bar Association’s quarterly newsletter, Bar Talk.

On June 24, 2024, the Department of Health and Human Services (“HHS”) released a final rule (“Disincentives Final Rule”) establishing disincentives for certain healthcare providers that have committed information blocking. The information blocking disincentives directly impact Medicare-enrolled healthcare providers or suppliers including hospitals, critical access hospitals, MIPS-eligible clinicians, and ACOs. The Disincentives Final Rule has been submitted to the Office of the Federal Register for publication and will become effective 30 days after Federal Register publication.Continue Reading Healthcare Providers Who Engage in Information Blocking Will Face Disincentives Described in an HHS Final Rule